Trump administration finalizes plan to cut federal Medicaid funds for youth trans care

The Trump administration has issued and finalized a rule banning federal Medicaid and CHIP funding for transgender youth care and gender-affirming treatments—including hormone therapy, puberty blockers, and surgeries—starting October 13. LGBTQ+ advocates strongly condemned the measure as dangerous and criticize it for holding vital healthcare funding hostage, while the rule leaves states the option to cover treatments using their own funds.

• Federal Medicaid funding for transgender youth care is cut starting October 13
• The rule applies to hormone therapy, puberty blockers, and surgeries
• States may still use their own funds to cover the care
• Federal Medicaid and CHIP funding for pediatric gender-affirming care has ended
• States retain the ability to cover these treatments using their own funds
• Trump administration issues rule banning Medicaid coverage for trans youth care
• LGBTQ+ groups condemn the measure as holding vital healthcare funding hostage
• The Trump administration is targeting Medicaid funding for gender-affirming care for transgender minors